Orexins (A and B) have been implicated in feeding behavior, energy balance and state of vigilance. During pregnancy, their involvement in feeding regulation and reproduction are poorly understood. In this study, we investigated orexin-A immunoreactivity in the hypothalamus and serum in pregnant rats and women by immunofluorescence staining, image analysis and radioimmunoassay, examined the correlation of serum orexin-A and leptin with gestational age in pregnant women by regression analysis, and explored the effect of leptin injected intracerebroventricularly (i.c.v.) on orexin-A immunoreactivity in the hypothalamus of normal rats by immunohistochemistry. The results showed that pregnant rats had significantly greater daily food intake on days 15 and 20 of pregnancy than virgin ones (+27·3%, P<0·01 and +38·6%, P<0·001 respectively), with significantly fewer number and lower mean staining intensity of orexin-A-immunoreactive (ir) neurons on days 16 (both P<0·05) and 21 (both P<0·01) of pregnancy. Moreover, serum levels of orexin-A exhibited 2·0-fold and 2·2-fold increases (both P<0·001) in rats on days 16 and 21 of pregnancy compared with those in virgin rats, and 1·9-fold and 2·0-fold increases (both P<0·001) in mid (13-26 weeks) and late pregnant women (27-40 weeks) compared with those in non-pregnant women. Simultaneously, serum levels of leptin showed a 2·3-fold and 2·2-fold increase (both P<0·001) in rats on days 16 and 21 of pregnancy, and a 3·3-fold and 4·3-fold increase (both P<0·001) in mid and late pregnant women. Serum levels of both orexin-A and leptin correlated positively with gestational age in pregnant women. Leptin injected i.c.v. significantly decreased the number (P<0·01) and mean staining intensity (P<0·01) of orexin-A-ir neurons in the hypothalamus, food intake (P<0·01) and body weight gain (P<0·001) compared with vehicle injection in normal rats. These results suggested that central and serum orexin-A might be involved in the regulation of feeding and energy metabolism during pregnancy. The change in central orexin-A immunoreactivity might be related to the increased serum leptin concentrations.
Introduction
The hypothalamus is an important integrating center of feeding and energy homeostasis. The lateral hypothalamic area (LHA) has long been considered as a feeding center (Bernardis & Bellinger 1996) . Orexins (A and B) are a novel family of peptides that were mainly discovered and characterized in the neurons located in the LHA. Orexin-A and orexin-B injected intracerebroventricularly (i.c.v.), even injected into the LHA at low doses, stimulate feeding (Sakurai et al. 1998 , Edwards et al. 1999 . Orexin-A is more potent than orexin-B in promoting feeding (Dube et al. 1999) . Orexins and their receptors (orexin 1 R and orexin 2 R) were initially identified in the brain (Sakurai 1999) . Recent data have shown that many peripheral tissues express orexin receptors (orexin 1 R and orexin 2 R) (Johren et al. 2001) and there is detectable orexin-A in the circulation (Arihara et al. 2001) . These data imply that circulating orexin-A may have some physiological actions, especially in the regulation of feeding and sleeping.
The mid and later stages of pregnancy are characterized by an increase in energy demand (Ota & Yokoyama 1967) . In lactating rats, we found a greater number and increased mean staining intensity of orexin-A-immunoreactive (ir) neurons in the LHA, increased daily food intake and body weight gain, unchanged prepro-orexin mRNA expression in the hypothalamus and decreased serum leptin levels (Sun et al. 2003 ). Involvement of orexins in feeding and reproductive function during pregnancy is not clear. Therefore, the purpose of this study was to evaluate the changes in orexin-A immunoreactivity in the hypothalamus and peripheral circulation in pregnant rats and women by immunofluorescence staining, image analysis and radioimmunoassay methods, and to explore the effects of an i.c.v. injection of leptin on orexin-A immunoreactive neurons in the hypothalamus of rats.
Materials and methods

Subjects and handling
Ten-week-old female Wistar rats weighing 220-250 g, and adult male Wistar rats weighing 280-320 g, were purchased from Charles-River (Yokohama, Japan) and housed individually in an air-conditioned room (23 2 C) under a 12 h light/darkness cycle (lights on from 0600 to 1800 h). Standard rat chow and tap water were available ad libitum throughout the experiment. After one week of adaptation, estrous cycles of female rats were determined by daily vaginal smears. On the third proestrous day of the observed estrous cycle, ten rats were mated with conspecific male rats and the mating day was considered as day 0 of pregnancy. Mated rats were divided into two groups, pregnancy I and pregnancy II, which were killed on days 16 and 21 of pregnancy respectively for orexin-A immunohistochemistry (Sun et al. 2003) . Briefly, rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) between 0900 and 1000 h, punctured through angular vein with a hepavinized glass capillary for the collection of blood samples, and then perfused with 150 ml 0·1 M phosphate buffer (PB, pH 7·4, 4 C) and 500 ml Zamboni's solution successively. The brains were removed quickly, immersed in the same fixative (4 C) for 24 h with gentle shaking and cryoprotected in 20% and 30% sucrose in 0·1 M PB (pH 7·4, 4 C) for 24 h respectively. After brain dissection, the pregnancy was confirmed by checking the uterus of each pregnant rat. Another five control rats, diestrum virgin rats, were treated in the same way as the pregnant rats. In the clinical experiment, 20 healthy non-pregnant and 53 normal pregnant women were recruited as control and experimental groups respectively, who were admitted to the Affiliated Hospital of the Medical College, Qingdao University from October 2003 to March 2004. The pregnant women had not suffered from any complications of pregnancy, such as pregnancy-induced hypertension, obesity (body mass index >25 kg/m 2 ), diabetes, anemia etc, and did not undergo any drug administration during pregnancy. They were divided into three groups: early (n=18, aged 28·3 2·9 years, <12 weeks pregnant), mid (n=18, aged 28·3 4·5, 13-26 weeks pregnant) and late (n=17, aged 30·2 3·8 years, 27-40 weeks pregnant) pregnancy according to their gestational weeks. None of the subjects had any remarkable past history. This protocol was approved by the Associate Committee of the Affiliated Hospital of the Medical College in Qingdao University in China.
Intracerebroventricular cannula placement and i.c.v. administration of leptin
Adult male Wistar rats, weighing 280-300 g, were anesthetized with sodium pentobarbital (45 mg/kg, i.p.) and placed in a stereotaxic frame. A 28-gauge stainless steel cannula was implanted into the right lateral cerebral ventricle. The coordinates of the guide cannula tip were identified from an atlas of the rat brain (Paxinos & Watson 1986) , 0·8 mm posterior to the bregma, 1·6 mm lateral to the midsagittal line and 4·3-4·5 mm ventral to the skull. After surgery, the cannula was fixed to the skull with four jeweler's screws and dental cement. A stainless steel plug was inserted into each cannula to prevent leakage of cerebral spinal fluid. The rats were allowed to recover for 7 days, and randomly subdivided into control and leptin groups (n=5/group). They were injected intracerebroventricularly with either 3 µl vehicle (phosphate buffered saline, PBS) or recombinant murine leptin (1 µg/µl; Prepro Tech EC Ltd, London, UK) dissolved in PBS at the beginning of the night phase (1800 h). Daily food intake and body weight gain were monitored for three days (from 1800 to 1800 h). On day 4 post injection, the same injections were repeated in the corresponding rats at 1800 h. The next morning (0900-1000 h), the rats were killed for immunohistochemistry of orexin-A (Sun et al. 2003) .
Central orexin-A immunoreactivity
The cryoprotected brains were quickly frozen in embedding solution with O.C.T. compound (Sakura Finetechnical Co. Ltd, Tokyo, Japan) in a cryostat (Leica CM1510, Nussloch, Germany). For pregnant rats, the brains were cut into 25 µm-thick coronal sections on the cryostat, collected in eight series (each series containing one eighth of all sections). One series of sections from each rat ranging from bregma -2·4 mm to bregma -3·6 mm was processed by immunofluorescence staining for orexin-A immunoreactivity. Briefly, sections were incubated in rabbit anti-orexin-A serum (1:2000; Peninsula Laboratories, San Carlos, CA, USA) in 0·01 M PBS (pH 7·4) with 0·1% Triton-X 100 for 48 h at 4 C, which is specific to orexin-A of human, mouse and rat. Thereafter, the sections were thoroughly rinsed in 0·01 M PBS and incubated with FITC-labeled anti-rabbit IgG antiserum (1:1000; Vector Laboratories, Burlingame, CA, USA) containing 2% normal rat serum for 1 h at room temperature. Sections were rinsed again in 0·01 M PBS, mounted with glycerine solution. The negative controls were processed by omission of primary antiserum. For rats treated with i.c.v. injected leptin or vehicle, the brain sections were processed for orexin-A immunoreactivity by immunohistochemistry methods described previously (Sun et al. 2003) rather than by immunofluorescence staining.
Quantitative analysis of immunoreactivity of orexin-A in the hypothalamus
Orexin-A immunoreactivity in each section processed by immunofluorescence staining was observed with a fluorescence microscope (AX80T, Olympus, Tokyo, Japan). The microscopic images ( 40) enclosing the population of orexin-A-ir neurons in the unilateral hypothalamic area on one section were taken using a digital camera (Olympus DP50, Tokyo, Japan) attached to the fluorescence microscope using Viewfinder Life software (version 1·0; Olympus Corporation, Tokyo, Japan) under the same parameters and conditions for each section. The size of images was 1392 1040 pixels. For one section, two images including the left and right hypothalamic area were taken. The MacSCOPE program (version 2·59; Mitani, Fukui, Japan) can give each pixel a gray level numbering between 0 and 255, representing pure black (full light absorption) and pure white (full light transmission) respectively. The mean staining intensity of orexin-A-ir neurons in each image was expressed as mean gray level (Weaver & Au 1997) by the MacSCOPE program. Neuronal counts were made for orexin-A-labeled neurons from each image according to the counting methods of MacSCOPE. Five sections (ten images) per rat, collected in every 200 µm tissue from bregma -2·6 mm to bregma -3·4 mm, were analyzed. The results were the mean of 10 images from five separate sections. In the leptin injection experiment, orexin-A immunoreactivity in each section processed by immunohistochemistry was observed with a Vanox-S microscope (AH-2, Olympus, Tokyo, Japan) as previously described (Sun et al. 2003) . The microscopic images (40 ) of stained sections were transported to a video monitor using a digital camera (HC-2500 3 CCD, Fujix, Tokyo, Japan) attached to a Vanox-S microscope using Fujifilm/Photograb-2500 software (version 1·1; Fuji Photo Film Co. Ltd, Tokyo, Japan). The number and mean staining intensity of orexin-A-ir neurons in each image were analyzed by the MacSCOPE program (version 2·56; Mitani Corp.) (Sun et al. 2003) .
Serum levels of orexin-A and leptin
For rats, blood samples were collected in the morning (09001000 h) on days 16 and 21 of pregnancy. Serum were separated within two hours and stored at 80 C. For pregnant and control women, blood samples were taken from the antecubital vein in the morning between 0730 and 0830 h after an overnight fast. Blood samples were centrifuged at 1500 g for 15 min. Serum samples were frozen and stored at 80 C. Serum orexin-A levels were measured with a commercially available RIA kit (Phoenix Pharmaceuticals, Inc., Belmont, CA, USA), which is suitable for the determination of orexin-A of mouse, rat and human in serum, plasma and tissue. Serum leptin concentrations were determined with two RIA kits (Linco Research Inc., St Charles, MO, USA). They are specific for rat leptin and human leptin respectively. Protocols for the assays followed the methods supplied by the providers. Serum orexin-A and leptin were assayed in duplicate, and expressed in terms of the orexin-A and leptin standards respectively. All the intra-and interassay levels were less than 8%.
Statistical analysis
All data are given as the mean S.E.M. Statistical significance of data was assessed by using one-way ANOVA followed by the Fisher's protected least significant difference test. In the leptin-treated experiment, data were analyzed by Student's t-test. P<0·05 was regarded as a statistically significant difference.
Results
Daily food intake in pregnant rats
Daily food intake was monitored in groups of virgin control, pregnancy I (on day 15 of pregnancy) and pregnancy II (on day 20 of pregnancy) rats. As shown in Fig. 1 , pregnant rats on days 15 and 20 of pregnancy had a significantly greater daily food intake than virgin control rats (+27·3%, P<0·01 and +38·6%, P<0·001 respectively).
The number and staining intensity of orexin-A-ir neurons in the hypothalamus in pregnant rats
The population of orexin-A-ir neurons in the unilateral hypothalamus of one section in groups of virgin control, pregnancy I (on day 16 of pregnancy) and pregnancy II (on day 21 of pregnancy) rats are shown in Fig. 2(A,B,C) . The number of orexin-A-ir neurons was significantly decreased in rats on days 16 (P<0·05 vs virgin) and 21 (P<0·01 vs virgin) of pregnancy (Fig. 2D) . The mean staining intensity of orexin-A-ir neurons was also lowered in rats on days 16 (P<0·05 vs virgin) and 21 of pregnancy (P<0·01 vs virgin) (Fig. 2E ).
Serum levels of orexin-A and leptin in pregnant rats and women
As shown in Fig. 3 , serum orexin-A concentrations were significantly increased 2·0-fold and 2·2-fold (both P<0·001) in pregnancy I (on day 16 of pregnancy) and pregnancy II (on day 21 of pregnancy) groups respectively compared with virgin rats (Fig. 3A) , and were significantly increased 1·9-fold and 2·0-fold (both P<0·001) in mid and late pregnant women respectively (but not in early pregnant women) compared with non-pregnant women (Fig. 3B) . Simultaneously, serum leptin concentrations showed a 2·3-fold and a 2·2-fold increase (both P<0·001) in pregnancy I and II groups (Fig. 3C) , and a 3·3-fold and 4·3-fold increase (both P<0·001) in mid and late pregnant women but not in early-pregnant women (Fig. 3D) .
Correlation of serum levels of orexin-A and leptin with gestational age in women
The result of regression analysis showed that serum levels of orexin-A (r=0·72, P<0·001; Fig. 4A ) and leptin (r=0·85, P<0·001; Fig. 4B ) correlated positively with gestational age in pregnant women.
Effects of i.c.v. injection of leptin on food intake, body weight gain and immunoreactivity of orexin-A in the hypothalamus in normal rats
As summarized in Table 1 , daily food intake and body weight gain were significantly decreased (P<0·01 and P<0·001 respectively) by i.c.v. injection of leptin in normal rats on day 1 but not on days 2 to 3 post injections. Orexin-A-ir neurons in the unilateral hypothalamus in vehicle-and leptin-treated normal rats are shown in Fig. 5(A,B) . The number and mean staining intensity of orexin-A-ir neurons were significantly decreased by i.c.v. injection of leptin in normal rats ( Fig. 5C, P<0·01; Fig. 5D, P<0·01) .
Discussion
In the present study, we observed that rats had significantly greater daily food intake on days 15 and 20 of pregnancy, decreased number and staining intensity of orexin-A-ir neurons on days 16 and 21 of pregnancy, and increased serum levels of orexin-A and leptin on days 16 and 21 of pregnancy compared with virgin rats. In clinical experiments, pregnant women in mid and late pregnancy exhibited significantly higher serum levels of orexin-A and leptin than non-pregnant women. Serum levels of orexin-A and leptin in pregnant women correlated positively with gestational age. To our 
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knowledge, the current data represent the first demonstration of the changes in orexin-A immunoreactivity in the hypothalamus and circulation of pregnant rats and women. Some data indicated that preproorexin mRNA expression during late pregnancy was lower than that on day 1 post partum in rats (Wang et al. 2003) . But Wang et al. did not study the difference in prepro-orexin mRNA expression in virgin and pregnant rats, and did not observe orexin-A immunoreactivity in their study. Previous studies on prepro-orexin mRNA expression during pregnancy are confusing, indicating opposite results. One group (Garcia et al. 2003) reported Table 1 Effect of i.c.v. leptin administration (3 µg/rat) on daily food intake and body weight gain in normal rats. Values are means±S.E.M (n=5 rats/group)
Daily food intake (g)
Body weight gain (g) decreased, while another group (Kanenishi et al. 2004) reported increased levels of prepro-orexin mRNA in the rat brain. Perhaps this discrepancy can be explained by the different methods used in the experiments. Our results indicate decreased levels of orexin-A immunoreactivity in the hypothalamus during pregnancy, which is in line with the observations of Garcia et al. However, orexin-A immunoreactivity in the hypothalamus during pregnancy is opposite to our previous observations during lactation (Sun et al. 2003) , indicating that hypothalamic orexin-A may have different roles in the hyperphagia induced by pregnancy and lactation. A regulatory role of leptin on orexin neurons has been speculated (Beck & Richy 1999 , Lopez et al. 2000 . Food deprivation decreased serum leptin concentrations and increased serum levels of orexin-A (Li et al. 1998 , Komaki et al. 2001 and hypothalamic prepro-orexin mRNA expression (Mondal et al. 1999) . The effect of food deprivation on prepro-orexin mRNA can be reversed by exogenous leptin administration (Lopez et al. 2000) and chronic treatment with leptin for 7 days significantly decreased orexin-A concentration in the LHA (Beck & Richy 1999) . Orexin neurons in the LHA express leptin receptors (Hakansson et al. 1999) . In addition, leptin inhibited the increase in intracellular calcium ion concentration ([Ca 2+ ]i) induced by a reduction in the glucose concentration of glucosesensitive neurons in the arcuate nucleus and LHA via the leptin receptor expressed in these neurons (Funahashi et al. 1999) . In this study, we observed that serum levels of leptin were increased in both pregnant rats and women, which is consistent with results previously reported (Johnstone & Higuchi 2001) . The total amount of leptin mRNA in maternal adipose tissues significantly increased as pregnancy advanced and reached about 2·5-fold that of non-pregnant rats on day 19 of pregnancy (Kawai et al. 1997) . In this study, we observed that leptin injected by the i.c.v. route significantly decreased the number and mean staining intensity of orexin-A-ir neurons in the hypothalamus. Taken together, the increase in leptin levels may contribute to the decrease in hypothalamic orexin-A immunoreactivity in pregnant rats through the activation of specific leptin receptors located on orexin neurons. We have no clear explanation why serum levels of orexin A were increased while central orexin-A levels were decreased in pregnant rats. Serum orexin-A might have other origins, such as the gut and pancreas. In addition, circulating orexin-A and leptin levels change inversely in relation to each other in fasting non-obese humans (Komaki et al. 2001) while in this study, they changed in parallel, indicating that the involvement of circulating orexin-A and leptin in pregnant rats and women differed from that in the fasting state. In addition, some (25%) LHA neurons are thought to be glucose-sensitive (Oomura et al. 1974 , Bernardis & Bellinger 1996 . The activity of isolated orexin neurons is inhibited by glucose (Yamanaka et al. 2003) , but it is difficult to explain the change in orexin-A immunoreactivity in terms of unchanged glucose levels in pregnant rats and women.
Recently, orexin-A has been implicated to play a role in reproduction. Immunoreactivity of orexin neurons changed during the estrous cycle in rats (Porkka-Heiskanen et al. 2004 ). Orexin-A or orexin-B administered intracerebroventricularly reduces serum luteinizing hormone (LH) levels and suppresses the pulsatile secretion of LH (Irahara et al. 2001 , Kok et al. 2004 , indicating an involvement of orexins in the regulation of reproductive endocrine functions. Coadministration of i.c.v. orexin-A and intravenous naloxone (a specific opioid antagonist) significantly restored the mean LH concentration and the pulse frequency, implying that orexin-A suppresses gonadotropinreleasing hormone secretion via beta-endorphin. These data suggest that the inhibition of the hypothalamicpituitary-ovarian axis during pregnancy may be related to the increase in orexin-A levels in the circulation.
In conclusion, we provide evidence that central and peripheral orexin-A immunoreactivities were down-and up-regulated respectively in pregnant rats. The change in circulating levels of orexin-A and leptin was consistent in pregnant women and rats. Serum levels of orexin-A and leptin correlated positively with gestational age in pregnant women. The central and peripheral changes in orexin-A might be involved in the feeding, sleeping, and energy balance in pregnant rats and women. The increase in circulating leptin during pregnancy might inhibit central orexin-A expression. The interaction and relationship between central and circulating orexin-A still remains unclear.
